158 related articles for article (PubMed ID: 8852444)
1. Trophoblast proliferation rate does not predict progression to persistent gestational trophoblastic disease in complete hydatidiform mole.
Jeffers MD; Richmond JA; Smith R
Int J Gynecol Pathol; 1996 Jan; 15(1):34-8. PubMed ID: 8852444
[TBL] [Abstract][Full Text] [Related]
2. [Pathology of gestational trophoblastic tumors].
Vuong PN; Guillet JL; Houissa-Vuong S; Lhommé C; Proust A; Cristalli B
Gynecol Obstet Fertil; 2000 Dec; 28(12):913-26. PubMed ID: 11192198
[TBL] [Abstract][Full Text] [Related]
3. Quantitative morphology. A study of the trophoblast.
Franke HR; Alons CL; Caron FJ; Boog MC; Oort J; Stolk JG
Virchows Arch A Pathol Anat Histopathol; 1985; 406(3):323-31. PubMed ID: 3923708
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease].
Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.
Braga A; Maestá I; Rocha Soares R; Elias KM; Custódio Domingues MA; Barbisan LF; Berkowitz RS
Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961
[TBL] [Abstract][Full Text] [Related]
6. Intact Chorionic Vesicle in Very Early Products of Conception Specimens: Clinicopathologic Features of 26 Cases That May Mimic Complete Hydatidiform Mole.
Kayraklioglu N; Gasper C; Cho SJ; Lage J; Rabban JT
Am J Surg Pathol; 2023 Mar; 47(3):397-408. PubMed ID: 36729386
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27(kip1), and Ki-67 in normal placenta and gestational trophoblastic disease.
Olvera M; Harris S; Amezcua CA; McCourty A; Rezk S; Koo C; Felix JC; Brynes RK
Mod Pathol; 2001 Oct; 14(10):1036-42. PubMed ID: 11598175
[TBL] [Abstract][Full Text] [Related]
8. Very early complete hydatidiform mole.
Keep D; Zaragoza MV; Hassold T; Redline RW
Hum Pathol; 1996 Jul; 27(7):708-13. PubMed ID: 8698316
[TBL] [Abstract][Full Text] [Related]
9. New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease.
Shih IM; Kurman RJ
Verh Dtsch Ges Pathol; 1997; 81():266-72. PubMed ID: 9474880
[TBL] [Abstract][Full Text] [Related]
10. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
Persaud V; Ganjei P; Nadji M
West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
[TBL] [Abstract][Full Text] [Related]
11. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy.
Pongcharoen S; Searle RF; Bulmer JN
Placenta; 2004 Apr; 25(4):321-30. PubMed ID: 15028424
[TBL] [Abstract][Full Text] [Related]
12. [Expression of p57 marker in differential diagnosis of complete and partial mole - correlation with DNA analysis].
Cierna Z; Palkovič M; Danihel Ml L; Danihel L; Repiská V; Vojtaššák J; Korbeľ M
Cesk Patol; 2012 Oct; 48(4):218-21. PubMed ID: 23121032
[TBL] [Abstract][Full Text] [Related]
13. Can Ki67 and Caspase Predict Molar Progression?
Nagib RM; M A Zaki M; Wageh A; Abdelrazik M
Fetal Pediatr Pathol; 2019 Oct; 38(5):444-448. PubMed ID: 31038005
[No Abstract] [Full Text] [Related]
14. Decidual infiltration of FoxP3⁺ regulatory T cells, CD3⁺ T cells, CD56⁺ decidual natural killer cells and Ki-67 trophoblast cells in hydatidiform mole compared to normal and ectopic pregnancies.
Sundara YT; Jordanova ES; Hernowo BS; Gandamihardja S; Fleuren GJ
Mol Med Rep; 2012 Jan; 5(1):275-81. PubMed ID: 22002546
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of the cell cycle promoter cyclin e in benign extravillous trophoblast and gestational trophoblastic lesions: correlation with expression of Ki-67.
Bamberger AM; Aupers S; Milde-Langosch K; Löning T
Int J Gynecol Pathol; 2003 Apr; 22(2):156-61. PubMed ID: 12649670
[TBL] [Abstract][Full Text] [Related]
16. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
[TBL] [Abstract][Full Text] [Related]
17. Expression pattern of the adhesion molecule CEACAM1 (C-CAM, CD66a, BGP) in gestational trophoblastic lesions.
Bamberger AM; Sudahl S; Wagener C; Löning T
Int J Gynecol Pathol; 2001 Apr; 20(2):160-5. PubMed ID: 11293162
[TBL] [Abstract][Full Text] [Related]
18. Comparison of villous trophoblast proliferation rate in hydatidiform mole and non-molar abortion by assessment of proliferating cell nuclear antigen expression.
Jeffers MD; Grehan D; Gillan JE
Placenta; 1994 Jul; 15(5):551-6. PubMed ID: 7997454
[TBL] [Abstract][Full Text] [Related]
19. The pathology of gestational trophoblastic disease: recent advances.
Wells M
Pathology; 2007 Feb; 39(1):88-96. PubMed ID: 17365825
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of leukemia inhibitory factor and insulin like growth factor-1 between normal pregnancies, partial hydatidiform moles and complete hydatidiform moles.
Yucel Cicek OS; Hekimoglu ER; Turgal M; Atilla P; Cakar AN; Usubutun A; Beksac MS
Placenta; 2018 Sep; 69():64-70. PubMed ID: 30213486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
